Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.20
+1.2%
$31.22
$27.07
$40.28
$1.47B1.34248,861 shs302,156 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$18.86
+0.5%
$12.56
$9.56
$18.93
$1.49B1.021.76 million shs2.85 million shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$12.95
-3.1%
$11.60
$5.45
$15.11
$424.15M2.04130,879 shs211,998 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$23.13
-1.4%
$18.75
$15.75
$53.69
$1.54B1.471.50 million shs1.46 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+0.98%+19.76%+16.31%-1.42%+14.17%
National Vision Holdings, Inc. stock logo
EYE
National Vision
+9.26%+41.58%+62.56%+61.03%+27.10%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
+3.72%+15.96%+28.31%+8.70%+57.29%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+2.05%+10.15%+37.46%-30.04%-47.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.6344 of 5 stars
1.53.02.50.02.13.31.9
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.6225 of 5 stars
2.32.00.03.34.00.00.0
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.3493 of 5 stars
2.43.00.00.02.64.20.6
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.7686 of 5 stars
4.34.00.04.93.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.00
Buy$37.002.21% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.50
Moderate Buy$17.57-6.83% Downside
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.80
Moderate Buy$15.2017.37% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.53
Moderate Buy$39.8172.12% Upside

Current Analyst Ratings Breakdown

Latest NPCE, TNDM, CDRE, and EYE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.00
5/9/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$13.00 ➝ $17.00
5/9/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$13.00 ➝ $21.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $15.00
5/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Buy
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$58.00 ➝ $59.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $31.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $20.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$36.00 ➝ $30.00
(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$559.81M2.63$1.58 per share22.89$5.25 per share6.90
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.85B0.81$2.68 per share7.03$10.60 per share1.78
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$79.91M5.31N/AN/A$0.79 per share16.39
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$982.95M1.57N/AN/A$4.81 per share4.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.64M$0.9543.6126.621.586.34%12.88%6.06%N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$65.90M-$0.33N/A69.853.27-0.81%3.52%1.39%N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$32.96M-$0.95N/AN/AN/A-36.74%-205.41%-28.29%5/14/2025 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$2.78N/AN/AN/A-14.84%-44.19%-11.99%N/A

Latest NPCE, TNDM, CDRE, and EYE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.26-$0.21+$0.05-$0.21$21.85 millionN/A
5/7/2025Q1 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.32$0.34+$0.02$0.18$510.30 million$510.32 million
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
4/30/2025Q1 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.60-$0.67-$0.07-$1.97$220.19 million$234.42 million
3/11/2025Q4 2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.48$0.32-$0.16$0.32$170.95 million$175.98 million
3/4/2025Q4 2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.25-$0.18+$0.07-$0.18$21.14 million$21.47 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.05%+63.55%40.00%2 Years
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Latest NPCE, TNDM, CDRE, and EYE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.65
3.01
1.96
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.30
0.57
0.37
NeuroPace, Inc. stock logo
NPCE
NeuroPace
6.03
5.59
4.77
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.29
2.90
2.32

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.30%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
22.20%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,24040.66 million25.58 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
14,00079.05 million76.94 millionOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17032.75 million23.22 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,60066.61 million64.23 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cadre stock logo

Cadre NYSE:CDRE

$36.20 +0.43 (+1.20%)
As of 03:53 PM Eastern

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

National Vision stock logo

National Vision NASDAQ:EYE

$18.86 +0.10 (+0.53%)
As of 04:00 PM Eastern

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$12.95 -0.42 (-3.14%)
As of 04:00 PM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$23.13 -0.32 (-1.36%)
As of 04:00 PM Eastern

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.